It is the time of year to renew our 68Ge/68Ga generator in BIOEMTECH Labs! By linking the pharmacokinetics of low molecular weight compounds to the brief physical half-life of 68Ga, an array of powerful, new clinical imaging studies is emerging. 68Ga-based peptides are increasingly recognized as a new class of radiopharmaceuticals, showing fast clearance and quick target localization. The short half-life of 68Ga (68 min) allows improved dosimetry and repeat imaging, making agents ideal for clinical use. Intrigued to be working with such compounds, which can soon prove promising for clinical practice and routine.

0

0